180 related articles for article (PubMed ID: 2458844)
1. Effect of treatment with glutaraldehyde-fixed myelin basic protein-liposomes on active induction and passive transfer of experimental allergic encephalomyelitis in Lewis rats.
Strejan GH; Gilbert JJ; St Louis J
Cell Immunol; 1988 Oct; 116(1):250-6. PubMed ID: 2458844
[TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental allergic encephalomyelitis in Lewis rats treated with myelin basic protein-liposome complexes: clinical, histopathological, and cell-mediated immunity correlates.
Strejan GH; Percy DH; St Louis J
Cell Immunol; 1984 Mar; 84(1):171-84. PubMed ID: 6199120
[TBL] [Abstract][Full Text] [Related]
3. Chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs: cell-mediated immunity and IgG isoelectric focusing in myelin basic protein-liposome-treated and untreated animals.
St Louis J; Gilbert JJ; Moscarello MA; Strejan GH
J Neuroimmunol; 1989 Feb; 21(2-3):137-47. PubMed ID: 2463997
[TBL] [Abstract][Full Text] [Related]
4. Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison.
Strejan GH; St Louis J
Cell Immunol; 1990 May; 127(2):284-98. PubMed ID: 1691689
[TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer of experimental allergic encephalomyelitis: recipient response to myelin basic protein-reactive lymphocytes.
Bouwer HG; Hinrichs DJ
J Neuroimmunol; 1994 Oct; 54(1-2):87-98. PubMed ID: 7523447
[TBL] [Abstract][Full Text] [Related]
6. Experimental allergic encephalomyelitis: clinical disease and enhanced cellular transfer in the absence of lymphocyte proliferative responses against syngeneic MBP.
Hunter S
Cell Immunol; 1986 Jan; 97(1):204-9. PubMed ID: 2427218
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
8. The role of myelin lipids in experimental allergic encephalomyelitis. III. Transfer of suppression from guinea pigs recovering from EAE, induced by myelin basic protein--galactocerebroside complexes.
Hosein ZZ; Gilbert JJ; Strejan GH
Cell Immunol; 1986 Apr; 99(1):265-78. PubMed ID: 2428529
[TBL] [Abstract][Full Text] [Related]
9. Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis.
Hilliard B; Ventura ES; Rostami A
Mult Scler; 1999 Feb; 5(1):2-9. PubMed ID: 10096096
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats.
Pope L; Paterson PY; Miller SD
J Neuroimmunol; 1992 Apr; 37(3):177-89. PubMed ID: 1373153
[TBL] [Abstract][Full Text] [Related]
11. The suppression of experimental allergic encephalomyelitis in Lewis rats by treatment with myelin basic protein-cell conjugates.
McKenna RM; Carter BG; Paterson JA; Sehon AH
Cell Immunol; 1983 Oct; 81(2):391-402. PubMed ID: 6196127
[TBL] [Abstract][Full Text] [Related]
12. Role of macrophage-myelin basic protein interaction in the induction of experimental allergic encephalomyelitis in Lewis rats.
Carbone AM; Ovadia H; Paterson PY
J Immunol; 1983 Sep; 131(3):1263-7. PubMed ID: 6193182
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental allergic encephalomyelitis in the Lewis rat, by administration of an acylated synthetic peptide of myelin basic protein.
St Louis J; Chan EL; Singh B; Strejan GH
J Neuroimmunol; 1997 Mar; 73(1-2):90-100. PubMed ID: 9058764
[TBL] [Abstract][Full Text] [Related]
14. Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease.
MacPhee IA; Mason DW
J Neuroimmunol; 1990 Apr; 27(1):9-19. PubMed ID: 1690754
[TBL] [Abstract][Full Text] [Related]
15. Treatment of spinal cord-induced experimental allergic encephalomyelitis in the Lewis rat with liposomes presenting central nervous system antigens.
Stein CS; St Louis J; Gilbert JJ; Strejan GH
J Neuroimmunol; 1990 Jul; 28(2):119-30. PubMed ID: 1694533
[TBL] [Abstract][Full Text] [Related]
16. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
Bouwer HG; Hinrichs DJ
J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
[TBL] [Abstract][Full Text] [Related]
17. Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes.
Mannie MD; Paterson PY; U'Prichard DC; Flouret G
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5515-9. PubMed ID: 3875098
[TBL] [Abstract][Full Text] [Related]
18. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
Frost H; Swanborg RH
Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species.
Miller A; Lider O; al-Sabbagh A; Weiner HL
J Neuroimmunol; 1992 Aug; 39(3):243-50. PubMed ID: 1379607
[TBL] [Abstract][Full Text] [Related]
20. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
